GentiBio snags $20m seed

GentiBio Inc, an emerging biotherapeutics company, has raised $20 million in seed funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this